Usefulness of thrombopoietin in the diagnosis of peripheral thrombocytopenias

Haematologica

Volumn 84, Issue 7, 1999, Pages 608-613

  Español, Ignacio ^a   Hernández, Angel ^a   Muńiz Diaz, Eduardo ^a   Ayats, Ramón ^a   Pujol Moix, Núria ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Autoimmune thrombocytopenic purpura; Human immunodeficiency virus; Liver diseases; Thrombocytopenia; Thrombopoietin

Indexed keywords

THROMBOPOIETIN;

ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOCYTOPENIC PURPURA;

HIV INFECTIONS; HUMANS; LIVER DISEASES; PLATELET COUNT; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; THROMBOCYTOPENIA; THROMBOPOIETIN;

EID: 17144446608     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Koike Y, Yoneyama A, Shirai J, et al. Evaluation of thrombopoiesis in thrombocytopenic disorders by simultaneous measurement of reticulated platelets of whole blood and serum thrombopoietin concentrations. Thromb Haemost 1998; 79:1106-10.
2. Shimada Y, Kato T, Ogami K, et al. Production of thrombopoietin (TPO) by rat hepatocytes and hepatoma cell lines. Exp Hematol 1995; 23:1388-96.
3. Sato T, Fuse A, Niimi H. Fielder PJ, Avraham H. Binding and regulation of thrombopoietin to human megakaryocytes. Br J Haematol 1998; 100:704-11.
4. Fielder PJ, Gurney AL, Stefanich E, et al. Regulation of thrombopoietin levels by c-mpl mediated binding to platelets. Blood 1996; 87:2154-61.
5. Emmons RVB, Reid DM, Cohen RL, et al. Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction. Blood 1996; 87:4068-71.
6. Mukai HY, Kojima H, Todokoro K, et al. Serum thrombopoietin (TPO) levels in patients with amegakaryocytic thrombocytopenia are much higher than those with immune thrombocytopenic purpura. Thromb Haemostasis 1996; 76:675-8.
7. Von dem Borne AEGKr, Vergheut FWA, Oosterhof F, Riesz LE, Brutel de la Riviere A, Engelfriet CP. A simple immunofluorescence test for the detection of platelet antibodies. Br J Haematol 1978; 35:195-207.
8. Keleman E, Cserhati I, Tanos B. Demonstration and some properties of human thrombopoietin in thrombocythemic sera. Acta Haematol 1958; 20:350-3.
9. Vigon Y, Mornon JP, Cocault L, et al. Molecular cloning and characterization of Mpl, the human homolog of the v-mpl oncogen: Identification of a member of the hematopoietic growth factor receptor superfamily. Proc Natl Acad Sci USA 1992; 89: 5640-4.
10. de Sauvage FJ, Hass PE, Spencer SD, et al. Stimulation of megakaryopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 1994; 369:533-8.
11. Bartley TD, Bogenberger J, Hunt P, et al. Identification and cloning of a megakatyocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell 1994; 77:1117-24.
12. Lok S, Kaushansky K, Holly RD, et al. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature 1994; 369:565-8.
13. Kaushansky K, Lok S, Holly RD, et al. Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature 1994; 369:568-71.
14. Wendling F, Maraskovsky E, Debili N, et al. c-Mpl ligand is a humoral regulator of megakaryocytopoiesis. Nature 1994; 369:571-4.
15. Zeigler FC, de Sauvage F, Widmer HR, et al. In vitro megakaryocytopoietic and thrombopoietic activity of c-mpl ligand (TPO) on purified murine hematopoietic stem cells. Blood 1994; 84:4045-52.
16. Choi ES, Hokom M, Bartley T, et al. Recombinant human megakaryocyte growth and development factor (rHuMGDF), a ligand for c-mpl, produces functional human platelets in vitro. Stem Cells 1995; 13:317-22.
17. Fanucchi M, Glaspy J, Crawford J, et al. Effects of polyethylene glycol-conjugated recombinant human megakaryocyte growth and development factor on platelets counts after chemotherapy for lung cancer. N Engl J Med 1997; 336:404-9.
18. Kaushansky K. Thrombopoietin: The primary regulator of platelet production. Blood 1995; 86:419-31.
19. Eaton DL, de Sauvage FJ. Thrombopoietin: The primary regulator of megakaryocytopoiesis and thrombopoiesis. Exp Hematol 1997; 25:1-7.
20. Sungaran R, Markovic B, Chong BH. Localization and regulation of thrombopoietin mRNA expression in human kidney, liver, bone marrow and spleen using in situ hybridization. Blood 1996; 89:101-7.
21. Fielder PJ, Hass P, Nagel M, et al. Human platelets as a model for the binding and degradation of thrombopoietin. Blood 1997; 89:2782-8.
22. Debili N, Wendling F, Cosman D, et al. The Mpl receptor is expressed in the megakaryocytic lineage from late progenitors to platelets. Blood 1995; 85: 391-401.
23. Marsh JCW, Gibson FM, Prue RL, et al. Serum thrombopoietin levels in patients with aplastic anaemia. Br J Haematol 1996; 95:605-10.
24. Ichikawa N, Ishida F, Shimodaira S, Tahara T, Kato T, Kitano K. Regulation of serum thrombopoietin levels by platelets and megakaryocytes in patients with aplastic anemia and idiopathic thrombocytopenic purpura. Thromb Haemost 1995; 76:156-60.
25. Kosugi S, Kurata Y, Tomiyama Y, et al. Circulating thrombopoietin level in chronic immune thrombocytopenic purpura. Br J Haematol 1996; 93:704-6.
26. Nagasawa T, Hasegawa Y, Shimizu S, et al. Serum thrombopoietin level is mainly regulated by megakaryocyte mass rather than platelet mass in human subjects. Br J Haematol 1998; 101:242-4.
27. Hirayama Y, Sakamaki S, Matsunaga T, et al. Con-Generations of thrombopoietin in bone marrow in normal subjects and in patients with idiopathic thrombocytopenic purpura, aplastic anemia, and essential thrombocythemia correlate with its mRNA expression on bone marrowstromal cells. Blood 1998; 92:46-52.
28. Harker LA, Finch CA. Thrombokinetics in man. J Clin Invest 1969; 48:963-74.
29. Qian S, Fu F, Li W, et al. Primary role of the liver in thrombopoietin production shown by tissue-specific knockout. Blood 1998; 92:2189-91.
30. Karpatkin S. Autoimmune (idiopathic) thrombocytopenic purpura. Lancet 1997; 349:1531-6.
31. Ballem PJ, Segal GM, Stratton JR, Gernsheimer T, Adamson JW, Slichter SJ. Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura: evidence of both impaired platelet production and increased platelet clearance. J Clin Invest 1987; 80:33-40.
32. Sakane Y, Wada H, Kazuyo H, et al. Increased thrombopoietin levels in idiopathic thrombocytopenic purpura patients with a poor response to steroid therapy. Blood Coag Fibrin 1998; 9:315-21.
33. Domínguez A, Gamallo G, García R, López-Pastor A, Peña JM, Vazquez JJ. Pathophysiology of HIV related thrombocytopenia: an analysis of 41 patients. J Clin Pathol 1994; 47:999-1003.
34. Ballem PJ, Belzberg A, Devine DV, et al. Kinetic studies of the mechanism of thrombocytopenia in patients with human immunodeficiency virus infection. N Engl J Med 1992; 327:1779-84.
35. Cole JL, Marzec UM, Gunthel CJ, et al. Ineffective platelet production in thrombocytopenic human immunodeficiency virus-infected patients. Blood 1998; 91:3239-46.